Monitoring Clinical Trial Data Using an Unblinded Industry Statistician

被引：0
|
作者：
Geraldine E. Baggs
Anand Seth
Jeffery S. Oliver
Wendy M. Jones
Linna Liu
Susan M. Toth
机构：
[1] Abbott Nutrition Research & Development,
[2] Abbott Laboratories,undefined
来源：
Drug information journal : DIJ / Drug Information Association | 2008年 / 42卷 / 2期
关键词：
Data monitoring committee; Unblinded industry statistician; FDA guidance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：193 / 199
页数：6
相关论文
共 26 条
  • [1] Monitoring clinical trial data using an unblinded industry statistician
    Baggs, Geraldine E.
    Seth, Anand
    Oliver, Jeffery S.
    Jones, Wendy M.
    Liu, Linna
    Toth, Susan M.
    DRUG INFORMATION JOURNAL, 2008, 42 (02): : 193 - 199
  • [2] The independent statistician for Data Monitoring Committees
    DeMets, DL
    Fleming, TR
    STATISTICS IN MEDICINE, 2004, 23 (10) : 1513 - 1517
  • [3] Coordinating Data Monitoring Committees and Adaptive Clinical Trial Designs
    Jay Herson
    Drug information journal : DIJ / Drug Information Association, 2008, 42 (4): : 297 - 301
  • [4] Coordinating data monitoring committees and adaptive clinical trial designs
    Herson, Jay
    DRUG INFORMATION JOURNAL, 2008, 42 (04): : 297 - 301
  • [5] Enhancing clarity of clinical trial safety reports for data monitoring committees
    Thomas, Sonia M.
    Jung, Kwanhye
    Sun, Hengrui
    Psioda, Matthew A.
    Quibrera, Pedro Miguel
    Strakowski, Stephen M.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2020, 30 (06) : 1147 - 1161
  • [6] Conflicts of interest in data monitoring of industry versus publicly financed clinical trials
    Lachin, JM
    STATISTICS IN MEDICINE, 2004, 23 (10) : 1519 - 1521
  • [7] An In-Process Scaling Model: A Potential Framework for Data Monitoring Committees and Clinical Trial Quality Improvement
    Alan Smith
    Jonathan Seltzer
    Drug information journal : DIJ / Drug Information Association, 2012, 46 : 8 - 12
  • [8] An In-Process Scaling Model: A Potential Framework for Data Monitoring Committees and Clinical Trial Quality Improvement
    Smith, Alan
    Seltzer, Jonathan
    DRUG INFORMATION JOURNAL, 2012, 46 (01): : 8 - 12
  • [9] Data monitoring committees for pragmatic clinical trials
    Ellenberg, Susan S.
    Culbertson, Richard
    Gillen, Daniel L.
    Goodman, Steven
    Schrandt, Suzanne
    Zirkle, Maryan
    CLINICAL TRIALS, 2015, 12 (05) : 530 - 536
  • [10] MONITORING OF CLINICAL-TRIALS AND INTERIM ANALYSES .1. THE DATA MONITORING COMMITTEE
    BOUTITIE, F
    BELLISSANT, E
    BLANCHARD, J
    BOISSEL, JP
    CAUQUIL, J
    CHAUVIN, F
    DERZKO, G
    DUCRUET, T
    DURRLEMAN, S
    GIRRE, JP
    LEIZOROVICZ, A
    MOCCATTI, D
    MUNOZ, A
    THERAPIE, 1992, 47 (04): : 345 - 349
123